GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » E10

Raia Drogasil (BSP:RADL3) E10 : R$0.51 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Raia Drogasil's adjusted earnings per share data for the three months ended in Mar. 2024 was R$0.113. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$0.51 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Raia Drogasil's average E10 Growth Rate was 18.60% per year. During the past 3 years, the average E10 Growth Rate was 20.50% per year. During the past 5 years, the average E10 Growth Rate was 19.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Raia Drogasil was 20.50% per year. The lowest was 19.30% per year. And the median was 20.50% per year.

As of today (2024-06-06), Raia Drogasil's current stock price is R$24.95. Raia Drogasil's E10 for the quarter that ended in Mar. 2024 was R$0.51. Raia Drogasil's Shiller PE Ratio of today is 48.92.

During the past 13 years, the highest Shiller PE Ratio of Raia Drogasil was 99.96. The lowest was 14.01. And the median was 62.50.


Raia Drogasil E10 Historical Data

The historical data trend for Raia Drogasil's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil E10 Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.28 0.34 0.42 0.49

Raia Drogasil Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.46 0.47 0.49 0.51

Competitive Comparison of Raia Drogasil's E10

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's Shiller PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Shiller PE Ratio falls into.



Raia Drogasil E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Raia Drogasil's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.113/159.3724*159.3724
=0.113

Current CPI (Mar. 2024) = 159.3724.

Raia Drogasil Quarterly Data

per share eps CPI Adj_EPS
201406 0.036 91.838 0.062
201409 0.040 92.602 0.069
201412 0.036 94.194 0.061
201503 0.000 97.799 0.000
201506 0.000 100.006 0.000
201509 0.000 101.392 0.000
201512 0.199 104.247 0.304
201603 0.053 106.979 0.079
201606 0.091 108.851 0.133
201609 0.068 109.986 0.099
201612 0.051 110.802 0.073
201703 0.061 111.869 0.087
201706 0.080 112.115 0.114
201709 0.079 112.777 0.112
201712 0.078 114.068 0.109
201803 0.071 114.868 0.099
201806 0.080 117.038 0.109
201809 0.075 117.881 0.101
201812 0.068 118.340 0.092
201903 0.052 120.124 0.069
201906 0.081 120.977 0.107
201909 0.268 121.292 0.352
201912 0.050 123.436 0.065
202003 0.072 124.092 0.092
202006 0.130 123.557 0.168
202009 0.090 125.095 0.115
202012 0.094 129.012 0.116
202103 0.101 131.660 0.122
202106 0.147 133.871 0.175
202109 0.090 137.913 0.104
202112 0.099 141.992 0.111
202203 0.081 146.537 0.088
202206 0.214 149.784 0.228
202209 0.130 147.800 0.140
202212 0.173 150.207 0.184
202303 0.114 153.352 0.118
202306 0.202 154.519 0.208
202309 0.156 155.464 0.160
202312 0.152 157.148 0.154
202403 0.113 159.372 0.113

Add all the adjusted EPS together and divide 10 will get our e10.


Raia Drogasil  (BSP:RADL3) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Raia Drogasil's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=24.95/0.51
=48.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Raia Drogasil was 99.96. The lowest was 14.01. And the median was 62.50.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Raia Drogasil E10 Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (BSP:RADL3) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines